The decreased secretion of GLP-1 and PYY is associated with the development of type 2 diabetes (T2D) and obesity (1, 11–16), and upregulating their secretion as observed in gastric bypass surgery can lead to remission/improvement of both obesity and T2D (17–20). Here, PYY is linked to obesity disorder.